Editorial | Open Access | Published 27th September 2020


PHSS News


Dear Readers



So as we come to nearly the end of Q3 of 2020 our world continues to change at a rapid rate.


I am extremely pleased to be able to share with you that the PHSS has just completed a very successful 2 day virtual conference, reaching over 60 attendees each day from around the UK & European region. I would like to extend my thank you to our speakers, partner UCL, sponsors, the attendees and PHSS team for delivering such an informative and insightful event.


We have also been able to deliver 2 excellent webinars providing updates on Annex 1 developments, demonstrating how the PHSS has been involved in reviewing and providing commentary opportunities to our membership and industry. We hope to be able to bring more of these invaluable sessions over the coming weeks and months. I would like to thank James Drinkwater and Di Morris, as well as the supporting members of the various focus groups who provided valuable contributions for their continued hard work and dedication to delivering these sessions, to help industry align and understand expectations from the regulations.


Our dedicated committee will continue to meet throughout the year albeit virtually, to ensure we are keeping you up to date with the latest industry developments and facilitate your involvement in key topics.


For more information about all our member benefits, and upcoming events please visit the PHSS website.

Please stay safe in the challenging times.


Jenni Tranter, Chair of PHSS – Pharmaceutical & Healthcare Sciences Society.